Multiple sclerosis in childhood: clinical features of 149 cases.
about
First-Line Disease-Modifying Therapies in Paediatric Multiple SclerosisPaediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesEstrogen and microglia: A regulatory system that affects the brain.Cognitive dysfunction in pediatric multiple sclerosis.Myelin and disorders that affect the formation and maintenance of this sheath.Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection.Mitochondrial DNA haplogroups and mutations in children with acquired central demyelinationDoes early-onset multiple sclerosis differ from adult-onset form in Iranian people.Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.Childhood multiple sclerosis and related disorders.Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.Extensive acute axonal damage in pediatric multiple sclerosis lesions.Ethical challenges in paediatric clinical trials in multiple sclerosisPediatric multiple sclerosis-a challenging demyelinating disease: case report and brief review of the literature.Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.Treatment of children and adolescents with multiple sclerosis.Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.Disease-modifying therapy of pediatric multiple sclerosis.Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan ProvinceInterferon-beta1b in multiple sclerosis.Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.Characteristics of Children and Adolescents With Multiple SclerosisEpidemiology of multiple sclerosis in Qom: Demographic study in IranPediatric multiple sclerosis: current concepts and consensus definitions.Use of a time-of-flight camera with an Omek Beckon™ framework to analyze, evaluate and correct in real time the verticality of multiple sclerosis patients during exercise.Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosisManagement of multiple sclerosis in adolescents - current treatment options and related adherence issues.Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.Time correlation between mononucleosis and initial symptoms of MS.Gender issues in multiple sclerosis: an update.Therapies for multiple sclerosis: considerations in the pediatric patient.Pathogenesis of pediatric multiple sclerosis.Neuropsychological correlates of multiple sclerosis across the lifespan.Prognostic indicators in pediatric clinically isolated syndrome.Use of Disease-Modifying Therapies in Pediatric MS.Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population.Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.Pediatric multiple sclerosis: updates in epidemiology, clinical features and management.
P2860
Q22241417-4C4C48D5-3472-49FF-AB6A-148F19A2ABEAQ26748229-9EA1C1A1-2FCE-45AC-B07F-862A39B2665FQ33714935-77855A33-483D-4585-BFF0-310DED369E39Q33968709-83F52EBB-420F-450E-84A3-5C96CD638DB9Q33971574-6A8DF86A-6A8B-4C59-A888-F7148D9577D0Q33999501-ACAB0E7E-A114-4128-8889-4B07F7CC4D53Q34647096-CD4A54E5-B5C7-417E-B003-BF9CA03AB721Q34863897-6639C623-9A0A-42F4-AAE5-1C82C00144E4Q35041978-05339C96-361A-44B3-A7C7-8239427E0721Q35803604-FE3394C7-1B20-4ECE-A19C-7743A8C0A74BQ35885503-55FCE9ED-AE6F-44F5-A35F-7736B2559455Q35913394-A6E4517E-6341-4CA3-B8B6-9EBB0AF75F2FQ35949329-668CF31E-BDE7-4E93-A4F7-05040A76EF3DQ36104365-69AE9FEB-0D18-4B55-9CBD-177146038F7CQ36133204-9730EA9A-F5B8-400B-96E4-69F52D1E4290Q36153390-3E9F46BB-3CA9-4643-8A20-30B8AF6FD9FFQ36153393-61F94CF8-CC45-4FEE-8E96-294D4F254E95Q36413401-491629A8-45B7-4009-A0AC-955D4FCC7D4BQ36537583-0753BA9F-28B3-4479-8D0F-8B6F591F2698Q36568645-3C7EDEC9-7C96-4868-BEDF-765F68F234B3Q36732954-C20F42DC-327D-4F63-B918-E54A3A5A293AQ36752915-09854943-DB03-4C37-98EE-5B0CF4CF3536Q36839814-10D40F70-A402-4D07-AE18-3976EE11DCDFQ37047475-D0BB9B6B-2652-4156-B825-C4BD592EFF6AQ37311807-A60A9201-F4D5-4BE5-952F-092236CBA6F7Q37330502-80F53D9B-1D3B-49BE-B387-BE031FB812E7Q37394001-EFD81CF8-2EA7-4E3C-AA8D-96D9C371F6E4Q37481523-A85F2876-E8A5-4BF3-B9A8-6655AE8F04D7Q37562003-71468464-0582-470E-95C6-22893C97AF8CQ37562166-F0A89A47-9C43-4735-991E-A86264CBBCA1Q37671515-A26DBA01-B45C-497D-9520-529880B8E9A9Q37813691-79193996-ADAF-4078-9983-CFFD22E89578Q37827690-442B43F5-1943-49C3-B870-C21394FE9E80Q38041081-D6308E23-D42E-4B4E-9201-8F9022433304Q38545084-2CD38A53-4F63-4075-BD91-05D566E35F81Q38821503-4BA8148E-20F9-4B29-AFFB-60583E94212FQ38868197-DB25A4BD-52C4-4406-97AD-3E8CF48CBA58Q38893094-9EE455B2-A888-4721-931A-EE3AB0CF10BBQ39919243-BB44FCA2-D802-4D18-BC4A-F3F11A2EAD2DQ40462419-49E87F19-62B1-4828-B5E7-42C5DBE87DF2
P2860
Multiple sclerosis in childhood: clinical features of 149 cases.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Multiple sclerosis in childhood: clinical features of 149 cases.
@en
Multiple sclerosis in childhood: clinical features of 149 cases.
@nl
type
label
Multiple sclerosis in childhood: clinical features of 149 cases.
@en
Multiple sclerosis in childhood: clinical features of 149 cases.
@nl
prefLabel
Multiple sclerosis in childhood: clinical features of 149 cases.
@en
Multiple sclerosis in childhood: clinical features of 149 cases.
@nl
P2093
P2860
P1476
Multiple sclerosis in childhood: clinical features of 149 cases.
@en
P2093
C Pozzilli
M G Grasso
M Zaffaroni
P2860
P356
10.1177/135245859700300105
P577
1997-02-01T00:00:00Z